Revising the WHO Essential Medicines List for paediatric rheumatology.
作者信息
Scott Christiaan, Smith Nicola, James Rebecca, Whitehead Ben, Green Rochelle, Foster Helen E
机构信息
Paediatric Rheumatology, University of Cape Town, Cape Town, South Africa.
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
出版信息
Pediatr Rheumatol Online J. 2021 Jan 23;19(1):10. doi: 10.1186/s12969-021-00496-3.
Abstract
摘要
相似文献
1
Revising the WHO Essential Medicines List for paediatric rheumatology.修订世界卫生组织儿童风湿病基本药物清单。
Pediatr Rheumatol Online J. 2021 Jan 23;19(1):10. doi: 10.1186/s12969-021-00496-3.
2
The selection and use of essential medicines.基本药物的选择与使用。
World Health Organ Tech Rep Ser. 2008(950):backcover, vii-174.
3
A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list.非洲儿童和青少年风湿病基本药物与世界卫生组织标准清单的定量比较。
Pediatr Rheumatol Online J. 2024 Jul 4;22(1):63. doi: 10.1186/s12969-024-00997-x.
4
Revising the WHO Essential Medicines List for paediatric rheumatology update.修订世界卫生组织儿科风湿病基本药物清单以进行更新。
Pediatr Rheumatol Online J. 2022 Oct 14;20(1):89. doi: 10.1186/s12969-022-00752-0.
5
The selection and use of essential medicines. Report of the WHO expert committee, 2005 (including the 14th model list of essential medicines).基本药物的选择与使用。世界卫生组织专家委员会报告，2005年（包括第14版基本药物示范目录）
World Health Organ Tech Rep Ser. 2006(933):1-119, back cover.
6
The Selection and Use of Essential Medicines.基本药物的选择与使用
World Health Organ Tech Rep Ser. 2015(994):vii-xv, 1-546.
7
The selection and use of essential medicines.基本药物的选择与使用。
World Health Organ Tech Rep Ser. 2011(965):i-xiv, 1-249.
8
Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.将世界卫生组织基本药物清单现代化以预防和控制心血管疾病。
J Am Coll Cardiol. 2018 Feb 6;71(5):564-574. doi: 10.1016/j.jacc.2017.11.056.
9
IAHPC List of Essential Medicines for Palliative Care: Summary of Process for Editors of Pain and Palliative Care Journals.
J Palliat Care. 2006 Winter;22(4):300-4.
10
The selection and use of essential medicines.基本药物的选择与使用。
World Health Organ Tech Rep Ser. 2009(958):1-242, back cover.
引用本文的文献
1
A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list.非洲儿童和青少年风湿病基本药物与世界卫生组织标准清单的定量比较。
Pediatr Rheumatol Online J. 2024 Jul 4;22(1):63. doi: 10.1186/s12969-024-00997-x.
2
Disability and disease-related damage in Thai children and adolescents with juvenile idiopathic arthritis.泰国青少年特发性关节炎患儿的残疾和疾病相关损伤。
Pediatr Rheumatol Online J. 2023 Jul 10;21(1):68. doi: 10.1186/s12969-023-00852-5.
3
Outcomes of intraarticular triamcinolone acetonide injection in children with non-systemic juvenile idiopathic arthritis.关节内曲安奈德注射治疗非全身型幼年特发性关节炎患儿的疗效。
Clin Rheumatol. 2023 Jun;42(6):1665-1674. doi: 10.1007/s10067-023-06569-w. Epub 2023 Mar 9.
4
Revising the WHO Essential Medicines List for paediatric rheumatology update.修订世界卫生组织儿科风湿病基本药物清单以进行更新。
Pediatr Rheumatol Online J. 2022 Oct 14;20(1):89. doi: 10.1186/s12969-022-00752-0.
5
Biologic medicine inclusion in 138 national essential medicines lists.生物医学纳入 138 个国家基本药物清单。
Pediatr Rheumatol Online J. 2021 Sep 6;19(1):140. doi: 10.1186/s12969-021-00608-z.
本文引用的文献
1
The paediatric global musculoskeletal task force - 'towards better MSK health for all'.儿科全球肌肉骨骼工作组 - “为所有人提供更好的肌肉骨骼健康”。
Pediatr Rheumatol Online J. 2020 Jul 14;18(1):60. doi: 10.1186/s12969-020-00451-8.
2
Update the WHO EML to improve global paediatric rheumatology.更新世界卫生组织基本药物清单以改善全球儿童风湿病学。
Nat Rev Rheumatol. 2020 Mar;16(3):123. doi: 10.1038/s41584-020-0368-6.
3
Treating juvenile idiopathic arthritis to target: recommendations of an international task force.靶向治疗幼年特发性关节炎：国际工作组的建议。
Ann Rheum Dis. 2018 Jun;77(6):819-828. doi: 10.1136/annrheumdis-2018-213030. Epub 2018 Apr 11.
Zotero 插件